Table of Contents

Genetics and Society: Perspectives from the Twenty-first Century Part 1: Biomedical Applications of New Genetic Technologies 1. Introduction 2. Biomedicalising Genetic Health, Diseases and Identities 3. Stem Cells, Translational Research and the Sociology of Science 4. Reproductive Genetics: From Choice to Ambivalence and Back Again 5. Localizing Genetic Testing and Screening in Cyprus and Germany: Contingencies, Continuities, Ordering Effects and Bio-cultural Intimacy 6. Nutrigenomics Part 2: Commercialisation Genomes and Markets 7. Introduction 8. Making Europe Unsafe for Agbiotech 9. Genetic Information and Insurance Underwriting: Contemporary Issues and Approaches in the Global Economy 10. On a Critical Path: Genomics, the Crisis of Pharmaceutical Productivity and the Search for Sustainability 11. States, Markets and Networks in Bioeconomy Knowledge Value Chains Part 3: Representations of Genomics 12. Introduction 13. Stakeholder Representations in Genomics 14. Human Genetics and Cloning in the Media: Mapping the Research Field 15. Cultural Imaginaries and Laboratories of the Real: Representing the Genetic Sciences 16. Genes In Our kNot Part 4: Regulation: Expressing the Gene 17. Introduction 18. Law and Regulation 19. Forensic DNA Databases and Biolegality: The Co-Production of Law, Surveillance Technology and Suspect Bodies 20. Bio-Banks and the Challenges of Governance, Legitimacy and Benefit Part 5: Bioethics and Genetics 21. Introduction 22. Rethinking Privacy in the Genetics Age 23. Bioethics and Human Genetic Engineering 24. Towards a Bioethics of Disability and Impairment 25. Ethical Perspectives on Animal Biotechnology Part 6: Diversity and Justice 26. Introduction 27. Religion and Nationhood: Collective Identities and the New Genetics 28. Extravagance or the Good and the Bad of Genetic Diversity 29. Eugenics 30. Human Dignity and Biotechnology Policy Part 7: New Forms of Knowledge Production 31. Introduction 32. Centralising Labels to Distribute Data: The Regulatory Role of Genomic Consortia 33. Innovative Genetic Technologies, Governance and Social Accountability 34. Genomic Platforms and Hybrid Formations